Analysts think ANL stock price could increase by 844%
Jun 14, 2024, 6:31 AM
4.01%
What does ANL do
Adlai Nortye Ltd, based in Kentucky, is a clinical-stage biotech company developing cancer therapies, with a pipeline featuring three clinical and three preclinical drug candidates. Their advanced drug, AN2025, targets solid tumors and is in Phase III trials for treating recurrent or metastatic head and neck cancers.
2 analysts think ANL stock price will increase by 844.44%. The current median analyst target is $30.60 compared to a current stock price of $3.24. The lowest analysts target is $30.30 and the highest analyst target is $31.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.